文献速递肝病

非酒精性脂肪性肝病与冠状动脉疾病的关系:一项孟德尔随机化研究

Relationship between NAFLD and coronary artery disease: A Mendelian randomization study.
PubMed 文献 · Hepatology · 2022-05-18

本研究采用两样本孟德尔随机化分析,评估遗传预测的非酒精性脂肪性肝病(NAFLD)与冠状动脉疾病(CAD)的因果关系。逆转方差加权分析显示,遗传预测的慢性丙氨酸氨基转移酶升高与CAD风险显著相关(OR:1.116,95%CI:1.039,1.199),而影像学诊断和活检确诊的NAFLD无显著关联;排除与VLDL分泌受损相关的基因后,所有NAFLD相关特征与CAD均显示一致关联。

要点

  • 遗传预测的慢性ALT升高与CAD风险显著相关(OR:1.116,95%CI:1.039,1.199)。
  • 排除VLDL分泌相关基因后,影像学诊断NAFLD与CAD关联增强(OR:2.149,95%CI:1.276,3.620)。
  • 活检确诊NAFLD在排除VLDL基因后与CAD关联(OR:1.113,95%CI:1.041,1.189)。

核心结论

  • 排除与VLDL分泌受损相关的遗传变异后,两样本孟德尔随机化分析显示遗传预测的NAFLD与CAD之间存在稳健关联。

研究设计与样本

  • 两样本孟德尔随机化分析,使用汇总水平数据评估遗传预测的NAFLD与CAD风险的关联。

主要发现

  • 逆转方差加权分析显示遗传预测的慢性ALT升高与CAD风险显著相关(OR:1.116,95%CI:1.039,1.199),影像学诊断NAFLD的OR为1.046(95%CI:0.764,1.433),活检确诊NAFLD的OR为1.014(95%CI:0.968,1.062),后两者未达统计学显著。
  • MR-Egger回归显示所有特征均有统计学显著的截距,提示存在方向性多效性。
  • 排除与VLDL分泌受损相关的基因后,慢性ALT升高与CAD的OR为1.203(95%CI:1.113,1.300),影像学诊断NAFLD的OR为2.149(95%CI:1.276,3.620),活检确诊NAFLD的OR为1.113(95%CI:1.041,1.189);采用更严格的活检确诊标准时OR为1.154(95%CI:1.043,1.278),采用更严格的MR方法时关联持续存在。
  • 排除VLDL相关基因后,MR-Egger回归未显示统计学显著的截距。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • MR-Egger回归在未排除VLDL相关基因的分析中显示统计学显著的截距,提示存在方向性多效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: There is an ongoing debate on whether NAFLD is an active contributor or an innocent bystander in the pathogenesis of coronary artery disease (CAD). The aim of the present study was to assess the causal relationship between NAFLD and CAD. APPROACH AND RESULTS: We performed two-sample Mendelian randomization (MR) analyses using summary-level data to assess the association between genetically predicted NAFLD (i.e., chronically elevated serum alanine aminotransferase levels [cALT], imaging-based and biopsy-confirmed NAFLD) and risk of CAD. Analyses were repeated after exclusion of NAFLD susceptibility genes that are associated with impaired VLDL secretion.Inverse-variance weighted MR analyses showed a statistically significant association between genetically predicted cALT and risk of CAD (OR: 1.116, 95% CI: 1.039, 1.199), but not for the other NAFLD-related traits (OR: 1.046, 95% CI: 0.764, 1.433 and OR: 1.014, 95% CI: 0.968, 1.062 for imaging-based and biopsy-confirmed NAFLD, respectively). MR-Egger regression revealed a statistically significant intercept, indicative of directional pleiotropy, for all traits. Repeat analyses after exclusion of genes associated with impaired VLDL secretion showed consistent associations between genetically predicted NAFLD and CAD for all traits (i.e., cALT [OR: 1.203, 95% CI: 1.113, 1.300]), imaging-based (OR: 2.149, 95% CI: 1.276, 3.620) and biopsy-confirmed NAFLD (OR: 1.113, 95% CI: 1.041, 1.189), which persisted when more stringent biopsy-confirmed NAFLD criteria were used (OR: 1.154, 95% CI: 1.043, 1.278) or when more stringent MR methods were applied. MR-Egger regression did not show a statistically significant intercept. CONCLUSION: The two-sample MR analyses showed a robust association between genetically predicted NAFLD and CAD after exclusion of genetic variants that are implicated in impaired VLDL secretion.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Ren Z, Simons PIHG, Wesselius A, et al. Relationship between NAFLD and coronary artery disease: A Mendelian randomization study. Hepatology. 2022. PMID: 35441719. doi:10.1002/hep.32534

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。